As innovation accelerates and evidence strengthens, CMS is recognizing the value of precision medicine diagnostic testing. Its latest decision is welcome news for hospitals and health systems, as well as patients with inherited breast or ovarian cancer...

De-identified data that hospitals and health systems share with big tech can sometimes be used to identify patients. As these types of deals grow, full transparency with patients is key...

While a recent report suggests expanding or initiating precision medicine efforts is imminent among health systems, some worry that precision medicine may take away from population health. The task for hospital and health system leaders is to determine a complementing balance of both efforts A report from the Center for Connected Medicine demonstrates just how …

Dilemma for Hospitals and Health Systems: Finding the Productive Middle Ground in the Precision Medicine vs Population Health Debate Read More »

The need to build up critical mass quickly may tempt hospital and health system leaders to cut corners when it comes to being forthcoming with patients. Don’t fall into that trap...

Effective communication with providers and patients can bridge the gap that exists between precision medicine’s benefits and wider patient access...

With precision medicine gaining momentum as a guiding approach to healthcare practice and treatments, early pharmacogenomic testing in the consumer market is laying some of the foundation for use in psychiatry...

Focus on pharmacogenetics studies and data that demonstrate costs savings and improved outcomes...

Focusing on the right factors can accelerate a precision medicine program’s ROI...

As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions...